Merck takes key step toward approval of experimental Ebola vaccine
The FDA indicated in the summer of 2016 that it had given Merck’s vaccine, provisionally called V920, a “breakthrough therapy designation.”…
Merck takes key step toward approval of experimental Ebola vaccine
Source: Virology News